Literature DB >> 23474498

Emerging phytochemicals for prevention of melanoma invasion.

Virginia Jones1, Santosh K Katiyar.   

Abstract

Cutaneous malignant melanoma is the leading cause of death from skin diseases due to its propensity to metastasize. Once diagnosed with metastatic melanoma, most patients will die of their disease within 2years. As suppression of metastases requires long-term interventions, potential anti-metastatic agents must not only be efficacious but also have low toxicity. Many phytochemicals used in traditional medicine have low toxicity and recent studies suggest that some are promising candidates for the prevention or treatment of metastatic melanoma. Here, we review the recent literature regarding phytochemicals that have shown inhibitory effects on melanoma cell migration or invasion.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474498      PMCID: PMC3744867          DOI: 10.1016/j.canlet.2013.02.056

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  74 in total

1.  Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation.

Authors:  Anshu Mittal; Craig A Elmets; Santosh K Katiyar
Journal:  Carcinogenesis       Date:  2003-06-05       Impact factor: 4.944

Review 2.  NF-kappaB and epithelial to mesenchymal transition of cancer.

Authors:  Chengyin Min; Sean F Eddy; David H Sherr; Gail E Sonenshein
Journal:  J Cell Biochem       Date:  2008-06-01       Impact factor: 4.429

Review 3.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

4.  Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression.

Authors:  Hak-Su Kim; Myung-Jin Kim; Eun Ju Kim; Young Yang; Myeong-Sok Lee; Jong-Seok Lim
Journal:  Biochem Pharmacol       Date:  2011-11-19       Impact factor: 5.858

5.  Inhibition of invasion and up-regulation of E-cadherin expression in human malignant melanoma cell line A375 by (-)-epigallocatechin-3-gallate.

Authors:  Yan Wu; Yun Lin; Houjun Liu; Jiawen Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

6.  An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells.

Authors:  Lu Wang; Yan Shen; Ran Song; Yang Sun; Jianliang Xu; Qiang Xu
Journal:  Mol Pharmacol       Date:  2009-09-24       Impact factor: 4.436

7.  Update on the incidence and mortality from melanoma in the United States.

Authors:  H I Hall; D R Miller; J D Rogers; B Bewerse
Journal:  J Am Acad Dermatol       Date:  1999-01       Impact factor: 11.527

8.  Suppression of adhesion-induced protein tyrosine phosphorylation decreases invasive and metastatic potentials of B16-BL6 melanoma cells by protein tyrosine kinase inhibitor genistein.

Authors:  C Yan; R Han
Journal:  Invasion Metastasis       Date:  1997

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

Review 10.  Epidemiology of invasive cutaneous melanoma.

Authors:  R M MacKie; A Hauschild; A M M Eggermont
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

View more
  8 in total

Review 1.  Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.

Authors:  Ross L Pearlman; Mary Katherine Montes de Oca; Harish Chandra Pal; Farrukh Afaq
Journal:  Cancer Lett       Date:  2017-01-25       Impact factor: 8.679

Review 2.  Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.

Authors:  Tomas Koltai; Larry Fliegel
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

3.  Therapeutic intervention of silymarin on the migration of non-small cell lung cancer cells is associated with the axis of multiple molecular targets including class 1 HDACs, ZEB1 expression, and restoration of miR-203 and E-cadherin expression.

Authors:  Tripti Singh; Ram Prasad; Santosh K Katiyar
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

4.  Down-regulation of miRNA-106b inhibits growth of melanoma cells by promoting G1-phase cell cycle arrest and reactivation of p21/WAF1/Cip1 protein.

Authors:  Ram Prasad; Santosh K Katiyar
Journal:  Oncotarget       Date:  2014-11-15

5.  Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice.

Authors:  Stefana Avram; Dorina-Elena Coricovac; Ioana Zinuca Pavel; Iulia Pinzaru; Roxana Ghiulai; Flavia Baderca; Codruta Soica; Danina Muntean; Daciana E Branisteanu; Demetrios A Spandidos; Aristides M Tsatsakis; Cristina Adriana Dehelean
Journal:  Oncol Rep       Date:  2017-05-22       Impact factor: 3.906

6.  Phytometabolite Dehydroleucodine Induces Cell Cycle Arrest, Apoptosis, and DNA Damage in Human Astrocytoma Cells through p73/p53 Regulation.

Authors:  Natalia Bailon-Moscoso; Gabriela González-Arévalo; Gabriela Velásquez-Rojas; Omar Malagon; Giovanni Vidari; Alejandro Zentella-Dehesa; Edward A Ratovitski; Patricia Ostrosky-Wegman
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

7.  Diminution of hepatic response to 7, 12-dimethylbenz(α)anthracene by ethyl acetate fraction of Acacia catechu willd. through modulation of xenobiotic and anti-oxidative enzymes in rats.

Authors:  Rakesh Kumar; Rajbir Kaur; Amrit Pal Singh; Saroj Arora
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

8.  Phenolic compounds from Viscum album tinctures enhanced antitumor activity in melanoma murine cancer cells.

Authors:  Michelle Nonato de Oliveira Melo; Adriana Passos Oliveira; Adalgisa Felippe Wiecikowski; Renato Sampaio Carvalho; Juliana de Lima Castro; Felipe Alves Gomes de Oliveira; Henrique Marcelo Gualberto Pereira; Venicio Feo da Veiga; Marcia Marques Alves Capella; Leandro Rocha; Carla Holandino
Journal:  Saudi Pharm J       Date:  2018-01-31       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.